NEW YORK, NY / ACCESS Newswire / September 28, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Integral Ad Science Holding Corp. ("IAS" or "the Company") (NASDAQ:IAS). Investors who purchased IAS securities prior to March 2, 2023, and continue to hold to the present, are encouraged to […]

NEW YORK CITY, NY / ACCESS Newswire / September 28, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Neogen Corporation ("Neogen" or "the Company") (NASDAQ:NEOG). Investors who purchased Neogen securities prior to January 5, 2025, and continue to hold to the present, are encouraged to obtain additional

NEW YORK, NY / ACCESS Newswire / September 28, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Lifecore Biomedical, Inc. ("Lifecore" or "the Company") (NASDAQ:LFCR). Investors who purchased Lifecore securities prior to October 7, 2020, and continue to hold to the present, are encouraged to obtain additional

NEW YORK, NY / ACCESS Newswire / September 28, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Acadia Healthcare Company, Inc. ("Acadia Healthcare" or "the Company") (NASDAQ:ACHC). Investors who purchased Acadia Healthcare securities prior to February 28, 2020, and continue to hold to the present, are encouraged

NEW YORK, NY / ACCESS Newswire / September 28, 2025 / If you suffered a loss on your Unicycive Therapeutics, Inc. (NASDAQ:UNCY) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/unicycive-therapeutics-inc-lawsuit-submission-form?prid=169820&wire=1&utm_campaign=10 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

NEW YORK CITY, NY / ACCESS Newswire / September 28, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of RxSight, Inc. ("RxSight" or "the Company") (NASDAQ:RXST). Investors who purchased RxSight securities prior to November 7, 2024, and continue to hold to the present, are encouraged to obtain additional

NEW YORK, NY / ACCESS Newswire / September 28, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Freeport-McMoran Inc. ("Freeport" or "the Company") (NYSE:FCX). Investors who purchased Freeport securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/FCX. Investigation Details

NEW YORK CITY, NY / ACCESS Newswire / September 28, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Globe Life Inc. ("Globe Life" or "the Company") (NYSE:GL). Investors who purchased Globe Life securities prior to May 8, 2019, and continue to hold to the present, are encouraged

NEW YORK CITY, NY / ACCESS Newswire / September 28, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Nextracker Inc. ("Nextracker" or "the Company") (NASDAQ:NXT). Investors who purchased Nextracker securities prior to February 1, 2024, and continue to hold to the present, are encouraged to obtain additional

NEW YORK CITY, NY / ACCESS Newswire / September 28, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Evolv Technologies Holdings, Inc. ("Evolv Technologies" or "the Company") (NASDAQ:EVLV). Investors who purchased Evolv Technologies securities prior to August 19, 2022, and continue to hold to the present, are